evernorth glp 1 New research shows GLP-1 medications - commonly used for type 2 diabetes and obesity Evernorth expands program to help
Description
Learn how GLP1 medication relates to midlife weight gain, HRT, muscle loss, appetite, side effects and long-term weight maintenance.
The treatment, which operates by targeting glucagon-like peptide-1 (GLP-1) receptors, falls within a class of drugs that are designed to affect the bodys insulin production and blood sugar levels
Who Its For: GLP-1 users
Hengrui agrees a $15.2bn R&D alliance with BMS in oncology/haematology and immunology, less than a year after a similar $12bn deal with GSK.
Protein ingredients are gaining ground as a result of GLP-1 drugs: 21 % calories, +11 % protein
A tribe of followers has emerged
